Marinus Pharmaceuticals Inc
NASDAQ:MRNS
Income Statement
Earnings Waterfall
Marinus Pharmaceuticals Inc
Revenue
|
31m
USD
|
Cost of Revenue
|
-1.9m
USD
|
Gross Profit
|
29.1m
USD
|
Operating Expenses
|
-160.5m
USD
|
Operating Income
|
-131.5m
USD
|
Other Expenses
|
-9.9m
USD
|
Net Income
|
-141.4m
USD
|
Income Statement
Marinus Pharmaceuticals Inc
Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||
Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
2
+912%
|
4
+105%
|
5
+54%
|
15
+183%
|
15
0%
|
28
+81%
|
28
0%
|
20
-28%
|
25
+28%
|
22
-15%
|
26
+20%
|
31
+19%
|
31
+0%
|
|
Gross Profit | ||||||||||||||||||||||||||||||||||||||||
Cost of Revenue |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(1)
|
(1)
|
(2)
|
(1)
|
(1)
|
(1)
|
(2)
|
|
Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
13
N/A
|
15
+14%
|
17
+15%
|
24
+40%
|
21
-12%
|
25
+19%
|
30
+18%
|
29
-2%
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(6)
|
(7)
|
(12)
|
(16)
|
(18)
|
(20)
|
(24)
|
(25)
|
(28)
|
(30)
|
(28)
|
(27)
|
(22)
|
(20)
|
(19)
|
(20)
|
(25)
|
(32)
|
(37)
|
(44)
|
(47)
|
(49)
|
(54)
|
(61)
|
(64)
|
(66)
|
(70)
|
(80)
|
(89)
|
(101)
|
(111)
|
(113)
|
(126)
|
(130)
|
(137)
|
(151)
|
(150)
|
(156)
|
(161)
|
|
Selling, General & Administrative |
(1)
|
(2)
|
(3)
|
(4)
|
(5)
|
(5)
|
(6)
|
(6)
|
(6)
|
(6)
|
(6)
|
(6)
|
(7)
|
(7)
|
(7)
|
(7)
|
(8)
|
(8)
|
(9)
|
(10)
|
(10)
|
(11)
|
(11)
|
(12)
|
(13)
|
(16)
|
(19)
|
(25)
|
(28)
|
(33)
|
(37)
|
(39)
|
(49)
|
(53)
|
(57)
|
(60)
|
(59)
|
(60)
|
(61)
|
|
Research & Development |
(5)
|
(6)
|
(9)
|
(12)
|
(13)
|
(15)
|
(19)
|
(19)
|
(22)
|
(24)
|
(22)
|
(20)
|
(16)
|
(13)
|
(12)
|
(13)
|
(17)
|
(24)
|
(28)
|
(33)
|
(36)
|
(39)
|
(43)
|
(49)
|
(51)
|
(51)
|
(51)
|
(55)
|
(62)
|
(69)
|
(74)
|
(73)
|
(76)
|
(77)
|
(80)
|
(90)
|
(90)
|
(94)
|
(99)
|
|
Operating Income |
(6)
N/A
|
(7)
-18%
|
(12)
-66%
|
(16)
-36%
|
(18)
-12%
|
(20)
-13%
|
(24)
-19%
|
(25)
-1%
|
(28)
-15%
|
(30)
-5%
|
(28)
+5%
|
(27)
+6%
|
(22)
+16%
|
(20)
+10%
|
(19)
+5%
|
(20)
-4%
|
(25)
-26%
|
(32)
-28%
|
(37)
-17%
|
(44)
-17%
|
(47)
-7%
|
(49)
-6%
|
(54)
-11%
|
(61)
-12%
|
(64)
-6%
|
(66)
-3%
|
(68)
-3%
|
(76)
-12%
|
(84)
-10%
|
(86)
-2%
|
(95)
-11%
|
(87)
+9%
|
(100)
-15%
|
(111)
-11%
|
(113)
-2%
|
(130)
-15%
|
(125)
+4%
|
(126)
-1%
|
(131)
-4%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
0
|
1
|
1
|
1
|
1
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
(0)
|
(1)
|
(3)
|
(4)
|
(6)
|
(8)
|
(8)
|
(8)
|
(8)
|
(8)
|
(9)
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(2)
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
(0)
|
|
Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
107
|
107
|
0
|
0
|
0
|
(4)
|
|
Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
1
|
(0)
|
(0)
|
(1)
|
(2)
|
106
|
107
|
0
|
1
|
|
Pre-Tax Income |
(6)
N/A
|
(6)
-8%
|
(11)
-70%
|
(16)
-44%
|
(18)
-13%
|
(21)
-19%
|
(25)
-19%
|
(25)
-1%
|
(29)
-15%
|
(30)
-5%
|
(29)
+5%
|
(27)
+6%
|
(22)
+16%
|
(20)
+10%
|
(19)
+6%
|
(19)
-3%
|
(24)
-25%
|
(31)
-28%
|
(37)
-17%
|
(43)
-18%
|
(46)
-7%
|
(49)
-6%
|
(54)
-11%
|
(60)
-11%
|
(64)
-5%
|
(65)
-3%
|
(67)
-3%
|
(76)
-13%
|
(84)
-11%
|
(88)
-5%
|
(99)
-12%
|
(91)
+8%
|
(107)
-17%
|
(12)
+89%
|
(16)
-36%
|
(32)
-94%
|
(26)
+19%
|
(134)
-418%
|
(143)
-7%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||
Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
(3)
|
0
|
(2)
|
(0)
|
2
|
|
Income from Continuing Operations |
(6)
|
(6)
|
(11)
|
(16)
|
(18)
|
(21)
|
(25)
|
(25)
|
(29)
|
(30)
|
(29)
|
(27)
|
(22)
|
(20)
|
(19)
|
(19)
|
(24)
|
(31)
|
(37)
|
(43)
|
(46)
|
(49)
|
(54)
|
(60)
|
(64)
|
(65)
|
(67)
|
(76)
|
(84)
|
(88)
|
(99)
|
(91)
|
(107)
|
(14)
|
(20)
|
(35)
|
(28)
|
(134)
|
(141)
|
|
Net Income (Common) |
(9)
N/A
|
(9)
+2%
|
(13)
-50%
|
(17)
-28%
|
(18)
-5%
|
(21)
-16%
|
(25)
-19%
|
(25)
-1%
|
(29)
-15%
|
(30)
-5%
|
(29)
+5%
|
(27)
+6%
|
(22)
+16%
|
(20)
+10%
|
(19)
+6%
|
(19)
-3%
|
(24)
-25%
|
(31)
-28%
|
(37)
-17%
|
(43)
-18%
|
(46)
-7%
|
(49)
-6%
|
(54)
-11%
|
(69)
-28%
|
(72)
-5%
|
(74)
-3%
|
(76)
-3%
|
(76)
+1%
|
(84)
-11%
|
(88)
-5%
|
(99)
-12%
|
(91)
+8%
|
(105)
-16%
|
(14)
+87%
|
(20)
-40%
|
(35)
-78%
|
(29)
+18%
|
(134)
-361%
|
(141)
-6%
|
|
EPS (Diluted) |
-2.99
N/A
|
-2.92
+2%
|
-8.7
-198%
|
-4.8
+45%
|
-5.03
-5%
|
-5.83
-16%
|
-6.66
-14%
|
-5.14
+23%
|
-5.88
-14%
|
-6.19
-5%
|
-5.88
+5%
|
-5.21
+11%
|
-4.08
+22%
|
-2.81
+31%
|
-3.21
-14%
|
-1.92
+40%
|
-2.41
-26%
|
-3.1
-29%
|
-3.59
-16%
|
-3.29
+8%
|
-3.51
-7%
|
-3.71
-6%
|
-3.97
-7%
|
-3.19
+20%
|
-2.9
+9%
|
-2.43
+16%
|
-2.8
-15%
|
-2.07
+26%
|
-2.29
-11%
|
-2.39
-4%
|
-2.69
-13%
|
-2.47
+8%
|
-2.78
-13%
|
-0.37
+87%
|
-0.51
-38%
|
-0.67
-31%
|
-0.55
+18%
|
-2.47
-349%
|
-2.63
-6%
|